• The angiographic technique of percutaneous transhepatic coronary vein occlusion was used to treat esophagogastric variceal bleeding in 38 patients. There were two categories of patients: those actively bleeding who had not been controlled by continuous vasopressin infusion and/or Blakemore tube tamponade, and those with portal hypertension who were not actively bleeding at the time of transhepatic portal venography but who were at high risk for recurrent variceal hemorrhage. Coronary vein occlusion was achieved in 33 patients by (1) metal clip and cotton devices (one); (2) balloon catheter occlusion (two); (3) heat-treated autogenous clot and powdered absorbable gelatin sponge (Gelfoam) (13); and (4) Gelfoam strips soaked in sodium tetradecyl sulfate (17). Percutaneous coronary vein occlusion was effective in controlling 81% of the patients with actively bleeding varices. In patients who were not actively bleeding, percutaneous transhepatic coronary vein occlusion seemed to afford good protection for recurrent variceal hemorrhage.
(Arch Surg 113:1331-1338, 1978)
Widrich WC, Johnson WC, Robbins AH, Nabseth DC. Esophagogastric Variceal HemorrhageIts Treatment by Percutaneous Transhepatic Coronary Vein Occlusion. Arch Surg. 1978;113(11):1331–1338. doi:10.1001/archsurg.1978.01370230121015
Customize your JAMA Network experience by selecting one or more topics from the list below.